Xenetic Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Xenetic Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Xenetic Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 1.54M shares, a 0.09% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.54M +1.46K +0.09% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 1.54M +9.54K +0.62% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 1.54M -13.6M -89.8% Mar 15, 2024 10-K 2024-03-21
Q3 2023 1.54M -13.6M -89.8% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 1.53M -12.8M -89.3% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 15.2M +1.73M +12.8% Mar 10, 2023 10-K 2023-03-22
Q3 2022 15.2M +1.78M +13.3% Nov 4, 2022 10-Q 2022-11-09
Q2 2022 14.3M +4.61M +47.5% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 13.4M +4.69M +53.7% Mar 18, 2022 10-K 2022-03-22
Q3 2021 13.4M +7.09M +113% Nov 5, 2021 10-Q 2021-11-12
Q2 2021 9.7M +3.41M +54.1% Aug 6, 2021 10-Q 2021-08-12
Q1 2021 8.75M +2.46M +39.2% Mar 11, 2021 10-K 2021-03-16
Q3 2020 6.3M +541K +9.4% Nov 9, 2020 10-Q 2020-11-12
Q2 2020 6.3M +2.55M +68.2% Aug 7, 2020 10-Q 2020-08-12
Q1 2020 6.28M -4.16M -39.8% Mar 6, 2020 10-K 2020-03-26
Q3 2019 5.76M -3.65M -38.8% Nov 8, 2019 10-Q 2019-11-14
Q2 2019 3.74M -5.66M -60.2% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 10.4M +1.79M +20.7% Mar 15, 2019 10-K 2019-03-29
Q3 2018 9.4M +686K +7.87% Nov 5, 2018 10-Q 2018-11-09
Q2 2018 9.4M +686K +7.87% Aug 6, 2018 10-Q 2018-08-10
Q1 2018 8.65M 0 0% Mar 30, 2018 10-K 2018-03-30
Q3 2017 8.72M +429K +5.18% Nov 13, 2017 10-Q 2017-11-14
Q2 2017 8.72M -300M -97.2% Aug 11, 2017 10-Q 2017-08-14
Q1 2017 8.65M -143M -94.3% Mar 30, 2017 10-K 2017-03-31
Q3 2016 8.29M Nov 14, 2016 10-Q 2016-11-14
Q2 2016 308M +158M +105% May 16, 2016 10-Q 2016-05-16
Q1 2016 152M +1.99M +1.33% Mar 30, 2016 10-K 2016-03-30
Q4 2015 151M Nov 16, 2015 10-Q 2015-11-16
Q2 2015 151M +3.77M +2.57% Aug 14, 2015 10-Q 2015-08-19
Q1 2015 150M +3.24M +2.21% Apr 10, 2015 10-K 2015-04-15
Q3 2014 147M Nov 14, 2014 10-Q 2014-11-14
Q2 2014 147M +11.7M +8.7% Aug 14, 2014 10-Q 2014-08-14
Q1 2014 147M +11.7M +8.7% Apr 15, 2014 10-K/A 2015-07-20
Q4 2013 135M +122M +900% Jan 3, 2014 10-Q 2014-01-10
Q2 2013 135M +122M +900% Jul 12, 2013 10-Q 2013-07-17
Q1 2013 135M +122M +900% Apr 18, 2013 10-Q 2013-04-22
Q4 2012 13.5M Jan 16, 2013 10-Q 2013-01-22
Q2 2012 13.5M Jul 10, 2012 10-Q 2012-07-16
Q1 2012 13.5M Apr 23, 2012 10-Q 2012-04-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.